Justin J. McAnear - 22 Nov 2022 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Financial Officer
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Justin J. McAnear
Issuer symbol
TXG
Transactions as of
22 Nov 2022
Net transactions value
-$55,392
Form type
4
Filing time
23 Nov 2022, 16:02:02 UTC
Previous filing
16 Sep 2022
Next filing
24 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale $23,369 -686 -0.88% $34.07 77,704 22 Nov 2022 Direct F1, F2
transaction TXG Class A Common Stock Sale $22,212 -652 -0.84% $34.07 77,052 22 Nov 2022 Direct F1
transaction TXG Class A Common Stock Sale $9,811 -288 -0.37% $34.07 76,764 22 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 Includes 1 share acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 14, 2022.